Position in RDY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,843,050
-$1,205,673 QoQ
Shares Held
334,234
-23.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#37
of 238 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $374,044,345 across 37 Drug Manufacturers - Specialty & Generic names. RDY ranks #14 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
5,284,773 | $130,058,261 | |
| 2 | VTRS |
Viatris Inc
|
3,165,469 | $50,267,647 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,105,005 | $37,437,568 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
185,545 | $31,271,754 | |
| 5 | ZTS |
Zoetis Inc.
|
237,394 | $17,059,132 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
188,565 | $12,058,731 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
690,897 | $11,959,425 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
98,305 | $10,905,956 |
All Filings in RDY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,843,050 | 334,234 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,048,723 | 436,731 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,419,540 | 243,557 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,041,107 | 146,002 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,865,763 | 124,136 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,287,818 | 97,636 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,304,648 | 82,625 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,315,134 | 16,553 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $985,516 | 12,935 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,858,888 | 38,976 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,570,980 | 36,950 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $311,948 | 4,665 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $272,193 | 4,313 | Shares | Sole | 2023-08-11 | |
| 2022-06-30 | $217,073 | 3,919 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $415,549 | 6,353 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $476,629 | 7,317 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $543,900 | 7,399 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $3,964,320 | 64,576 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $4,603,623 | 64,576 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $11,232,548 | 161,480 | Shares | Sole | 2020-12-04 | |
| 2020-06-30 | $6,487,151 | 122,376 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $5,299,563 | 131,405 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||